Kouichi Funato

Dr. Kouichi Funato


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2008 in Molecular Biology of the Cell
Verified
Journal Article
Closed access
KKKentaro Kajiwara
Kentaro Kajiwara
RWReika Watanabe
Reika Watanabe
HPHarald Pichler
Harald Pichler
KIKensuke Ihara
Kensuke Ihara
SMSuguru Murakami
Suguru Murakami
KFKouichi Funato
Kouichi Funato
Glycosylphosphatidylinositol (GPI), covalently attached to many eukaryotic proteins, not only acts as a membrane anchor but is also thought to be a sorting signal for GPI-anchored proteins that are associated with sphingolipid and sterol-enriched domains. GPI anchors contain a core structure conserved among all species. The core structure is synthesized in two topologically distinct stages on the leaflets of the endoplasmic reticulum (ER). Early GPI intermediates are assembled on the cytoplasmic side of the ER and then are flipped into the ER lumen where a complete GPI precursor is synthesized and transferred to protein. The flipping process is predicted to be mediated by a protein referred as flippase; however, its existence has not been proven. Here we show that yeast Arv1p is an important protein required for the delivery of an early GPI intermediate, GlcN-acylPI, to the first mannosyltransferase of GPI synthesis in the ER lumen. We also provide evidence that ARV1 deletion and mutations in other proteins involved in GPI anchor synthesis affect inositol phosphorylceramide synthesis as well as the intracellular distribution and amounts of sterols, suggesting a role of GPI anchor synthesis in lipid flow from the ER.

15 October 2012 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
KKKentaro Kajiwara
Kentaro Kajiwara
TMTetsuya Muneoka
Tetsuya Muneoka
YWYu Watanabe
Yu Watanabe
TKTakefumi Karashima
Takefumi Karashima
HKHiroshi Kitagaki
Hiroshi Kitagaki
KFKouichi Funato
Kouichi Funato
Summary: Sphingolipids are a class of membrane lipids conserved from yeast to mammals which determine whether a cell dies or survives. Perturbations in sphingolipid metabolism cause apoptotic cell death. Recent studies indicate that reduced sphingolipid levels trigger the cell death, but little is known about the mechanisms. In the budding yeast Saccharomyces cerevisiae, we show that reduction in complex sphingolipid levels causes loss of viability, most likely due to the induction of mitochondria‐dependent apoptotic cell death pathway, accompanied by changes in mitochondrial and endoplasmic reticulum morphology and endoplasmic reticulum stress. Elevated cytosolic free calcium is required for the loss of viability. These results indicate that complex sphingolipids are essential for maintaining endoplasmic reticulum homeostasis and suggest that perturbation in complex sphingolipid levels activates an endoplasmic reticulum stress‐mediated and calcium‐dependent pathway to propagate apoptotic signals to the mitochondria.

1 October 2020 in iScience
Verified
Journal Article
Open access
AIAtsuko Ikeda
Atsuko Ikeda
PSPhilipp Schlarmann
Philipp Schlarmann
KKKazuo Kurokawa
Kazuo Kurokawa
ANAkihiko Nakano
Akihiko Nakano
HRHoward Riezman
Howard Riezman
KFKouichi Funato
Kouichi Funato
Lipid composition varies among organelles, and the distinct lipid composition is important for specific functions of each membrane. Lipid transport between organelles, which is critical for the maintenance of membrane lipid composition, occurs by either vesicular or non-vesicular mechanisms. In yeast, ceramide synthesized in the endoplasmic reticulum (ER) is transported to the Golgi apparatus where inositolphosphorylceramide (IPC) is formed. Here we show that a fraction of Tcb3p, a yeast tricalbin protein, localizes to ER-Golgi contact sites. Tcb3p and their homologs Tcb1p and Tcb2p are required for formation of ER-Golgi contacts and non-vesicular ceramide transport. Absence of Tcb1p, Tcb2p, and Tcb3p increases acylceramide synthesis and subsequent lipid droplet (LD) formation. As LD can sequester excess lipids, we propose that tricalbins act as regulators of ceramide transport at ER-Golgi contact sites to help reduce a potentially toxic accumulation of ceramides.

1 January 2013 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
KKKentaro Kajiwara
Kentaro Kajiwara
AIAtsuko Ikeda
Atsuko Ikeda
AAAuxiliadora Aguilera-Romero
Auxiliadora Aguilera-Romero
GCGuillaume A. Castillon
Guillaume A. Castillon
SKSatoshi Kagiwada
Satoshi Kagiwada
KFKouichi Funato
Kouichi Funato
Lipids synthesized at the endoplasmic reticulum (ER) are delivered to the Golgi by vesicular and non-vesicular pathways. ER-to-Golgi transport is critical for maintaining the different membrane lipid composition and identities of organelles. Despite their importance, mechanisms regulating transport remain elusive. Here we report that coat protein complex II (COPII) vesicle-mediated transport of ceramide from the ER to the Golgi requires the yeast oxysterol-binding protein homologs, Osh proteins, which have been implicated in lipid homeostasis. Because Osh proteins are not required to transport proteins to the Golgi, these results indicate a specific requirement for the Osh proteins in the transport of ceramide. In addition, we provide evidence that Osh proteins play a negative role in COPII vesicle biogenesis. Together, our data suggest that ceramide transport and sphingolipid levels between the ER and Golgi are maintained by two distinct functions of Osh proteins, which negatively regulate COPII vesicle formation and positively control the late stage, presumably fusion of ceramide-enriched vesicles with Golgi compartments.

17 November 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SMSuguru Murakami
Suguru Murakami
TSToshi Shimamoto
Toshi Shimamoto
HNHideaki Nagano
Hideaki Nagano
MTMasahiro Tsuruno
Masahiro Tsuruno
HOHiroaki Okuhara
Hiroaki Okuhara
KFKouichi Funato
Kouichi Funato
Ceramide is one of the most important intercellular components responsible for the barrier and moisture retention functions of the skin. Because of the risks involved with using products of animal origin and the low productivity of plants, the availability of ceramides is currently limited. In this study, we successfully developed a system that produces sphingosine-containing human ceramide-NS in the yeast Saccharomyces cerevisiae by eliminating the genes for yeast sphingolipid hydroxylases (encoded by SUR2 and SCS7) and introducing the gene for a human sphingolipid desaturase (encoded by DES1). The inactivation of the ceramidase gene YDC1, overexpression of the inositol phosphosphingolipid phospholipase C gene ISC1 and endoplasmic reticulum localization of the DES1 gene product resulted in enhanced production of ceramide-NS. The engineered yeast strains can serve as hosts not only for providing a sustainable source of ceramide-NS but also for developing further systems to produce sphingosine-containing sphingolipids.

1 January 2020 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
KFKouichi Funato
Kouichi Funato
HRHoward Riezman
Howard Riezman
MMMANUEL MUÑIZ
MANUEL MUÑIZ